Is there momentum for exploration of disease-mongering?
In 2006, an Inaugural Congress on Disease Mongering met in Australia.
In October of 2010, I flew to Amsterdam to attend an international conference called “Selling Sickness.”
Well, “Selling Sickness” comes to the U.S. February 20-22 – with a conference, “Selling Sickness 2013: People Before Profits,” in Washington, DC.
(Although it might be pointed out that “selling sickness” has, indeed, in practice, already come to the U.S. and may have even been invented here.)
The driving force behind the event is Kim Witczak, whose husband Woody committed suicide while taking an antidepressant that was prescribed for insomnia, according to the Woody Matters website that Kim created. She attended the Amsterdam 2010 event and was immediately inspired to plan a U.S. version. Her co-organizer was Leonore Tiefer, PhD, who may be best known for her writings about the disease-mongering of female sexual dysfunction.
A pdf file of the program and schedule is available online.
Speakers include:
I’ll moderate a roundtable discussion on the dissemination of health care news from journals and journalists. A quick search using “disease-mongering” as our search term yields many results of things we’ve written about on the topic in recent years, including the sub-themes of:
To get the full context on what we’ve written about these topics, you’ll need to search on the site.
Maybe I’ll see you in Washington.
——————————————–
Addendum on May 21: The BMJ published an editorial, “A call to challenge the ‘Selling of Sickness.’ ”
——————————————-
Follow us on Facebook, and on Twitter:
https://twitter.com/garyschwitzer
https://twitter.com/healthnewsrevu
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Joleen Chambers
February 15, 2013 at 5:37 pmWe will meet there. @JjrkCh and blogspot, Failed Implanted Device Alliance. Kim Witczak was one of the first patient advocates I met in DC. Her admonition to ‘follow the money’ has been true north for my research. I look forward to learning from all presenters and participants.
kgapo
February 18, 2013 at 9:53 amThanks for the information on this important event! Do you know whether there will be live-streaming or vidoes of the presentations to watch afterwards? What is the conf. twitter hashtag?
Gary Schwitzer
February 18, 2013 at 1:09 pmKathi,
Sorry but I don’t know either answer. Check conference website.
Gary
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like